Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Groton, Connecticut 06340


Purpose:

To evaluate the efficacy and safety of azithromycin given chronically for the treatment of Mycobacterium avium (MAC) bacteremia in patients failing or intolerant of current available MAC therapy.


Criteria:

Inclusion Criteria Patients must have: - Disseminated MAC as defined by current (within the last month) positive blood, bone marrow, or liver biopsy culture for MAC, and considered symptomatic (fever, night sweats, anorexia, weight loss, fatigue, or malaise). - At least 2 months of prior treatment with available combination MAC therapy or less than 2 months of such accompanied by unacceptable adverse effects. - Life expectancy of more than 2 weeks. - Approval of eligibility from Pfizer Clinical Monitor. - Consent of parent or guardian if under legal age of consent. NOTE: - Patients who have completed acute treatment with azithromycin for MAC in protocol 066-131 or 066-148 will be exempt from inclusion criteria 1 and 2 and can continue therapy through this protocol if their physician feels they have benefitted from prior azithromycin therapy. Exclusion Criteria Co-existing Condition: Patients with the following symptoms and conditions are excluded: - Known hypersensitivity or intolerance to macrolide antibiotics. - Inability to take oral medications or current condition that is likely to interfere with absorption (e.g., gastrectomy). Concurrent Medication: Excluded: - Other MAC therapy instituted during the first 2 months of the study. - Other investigational drugs, with the exception of those available through a Treatment IND program. Patients with the following prior conditions are excluded: History of hypersensitivity or intolerance to azithromycin. Prior Medication: Excluded: - Other investigational drugs within 7 days of enrollment, with the exception of Treatment IND drugs (such as ddC).


NCT ID:

NCT00002089


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Groton, Connecticut 06340
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.